- Home
- HSCS vs ICU Comparison
HSCS vs ICU Comparison
Compare HSCS & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSCS | ICU |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 13.8M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HSCS | ICU |
|---|---|---|
| Price | $3.44 | $3.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 136.9K | 46.3K |
| Earning Date | 03-16-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,319.00 | ★ $1,234,000.00 |
| Revenue This Year | N/A | $53.00 |
| Revenue Next Year | N/A | $50.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 814.07 |
| 52 Week Low | $1.63 | $0.22 |
| 52 Week High | $4.35 | $5.38 |
Technical Indicators
Market Signals| Indicator | HSCS | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 57.75 | 43.72 |
| Support Level | $1.88 | $2.90 |
| Resistance Level | $3.57 | $3.50 |
| Average True Range (ATR) | 0.35 | 0.15 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 39.01 | 40.06 |
Price Performance
Historical ComparisonAbout HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.